Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|February 24, 2022
Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research LaboratoryHartmut Beck, Michael Härter, Bastian Haß, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Biphenyls as potent vitronectin receptor antagonistsKlaus Urbahns, Michael Härter, Markus Albers, et al.
European Journal of Medicinal Chemistry|December 22, 2018
Novel non-xanthine antagonist of the A2B adenosine receptor: From HTS hit to lead structureMichael Härter, Bernd Kalthof, Martina Delbeck, et al.
Arzneimittel-Forschung|April 17, 2008
Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosisAndreas Knorr, Claudia Hirth-Dietrich, Cristina Alonso-Alija, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Biphenyls as potent vitronectin receptor antagonists. Part 2: biphenylalanine ureasKlaus Urbahns, Michael Härter, Andrea Vaupel, et al.
Chemmedchem|November 29, 2013
Inhibition of hypoxia-induced gene transcription by substituted pyrazolyl oxadiazoles: initial lead generation and structure-activity relationshipsMichael Härter, Karl-Heinz Thierauch, Stephen Boyer, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2007
Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amidesKlaus Urbahns, Michael Härter, Markus Albers, et al.
Pageof 1